Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 84.47
(0.86%)
CNY 84.47
(0.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.92 Billion CNY | -212.18% |
| 2022 | -935.71 Million CNY | 21.86% |
| 2021 | -1.19 Billion CNY | -15.95% |
| 2020 | -1.03 Billion CNY | -16.61% |
| 2019 | -885.62 Million CNY | -1723.12% |
| 2018 | -48.57 Million CNY | -57.25% |
| 2017 | -30.89 Million CNY | -14.42% |
| 2016 | -27 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.44 Billion CNY | 50.68% |
| 2024 Q2 | -1.9 Billion CNY | -32.48% |
| 2024 Q3 | -1.59 Billion CNY | 16.73% |
| 2023 Q4 | -2.92 Billion CNY | -537.78% |
| 2023 FY | -2.92 Billion CNY | -212.18% |
| 2023 Q3 | -458 Million CNY | 52.65% |
| 2023 Q2 | -967.32 Million CNY | 6.3% |
| 2023 Q1 | -1.03 Billion CNY | -10.33% |
| 2022 Q4 | -935.71 Million CNY | 6.6% |
| 2022 Q3 | -1 Billion CNY | 21.92% |
| 2022 Q2 | -1.28 Billion CNY | -28.36% |
| 2022 Q1 | -999.61 Million CNY | 16.52% |
| 2022 FY | -935.71 Million CNY | 21.86% |
| 2021 FY | -1.19 Billion CNY | -15.95% |
| 2021 Q1 | -603.7 Million CNY | 42.57% |
| 2021 Q2 | -1.08 Billion CNY | -79.94% |
| 2021 Q3 | -614.95 Million CNY | 43.39% |
| 2021 Q4 | -1.19 Billion CNY | -94.72% |
| 2020 Q1 | -944.31 Million CNY | -6.63% |
| 2020 Q4 | -1.05 Billion CNY | -7.52% |
| 2020 Q3 | -977.66 Million CNY | -4.68% |
| 2020 Q2 | -933.92 Million CNY | 1.1% |
| 2020 FY | -1.03 Billion CNY | -16.61% |
| 2019 Q4 | -885.62 Million CNY | -3.23% |
| 2019 Q3 | -857.91 Million CNY | -859.57% |
| 2019 FY | -885.62 Million CNY | -1723.12% |
| 2019 Q1 | 49.9 Million CNY | 202.72% |
| 2019 Q2 | -89.4 Million CNY | -279.17% |
| 2018 Q4 | -48.57 Million CNY | 0.0% |
| 2018 FY | -48.57 Million CNY | -57.25% |
| 2017 FY | -30.89 Million CNY | -14.42% |
| 2016 FY | -27 Million CNY | 0.0% |